Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLAR study of systemic absorption of locally administered antibiotics in open fracture or fracture-related infection
NL-OMON22256Recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2021
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of gentamicin in open fracture and fracture-related infection (FRI) (2 cohorts), sponsored by Erasmus MC. Primary endpoint: Systemic concentration of the locally administered antibiotic. Started Jun 2021; status: recruiting.
02
Drugs
gentamicin
03
Conditions
open fracturefracture-related infection (FRI)
Beyond the preview
Go deeper on NL-OMON22256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22256.